Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Olga Delgado-Sanchez"'
Autor:
Miguel G. Uriol-Rivera, Aina Obrador-Mulet, Maria Rosa Juliá, Vanessa Daza-Cajigal, Olga Delgado-Sanchez, Angel Garcia Alvarez, Ana Gomez-Lobon, Paula Carrillo-Garcia, Carlos Saus-Sarrias, Cristina Gómez-Cobo, Daniel Ramis-Cabrer, Joan Gasco Company, Javier Molina-Infante, The Balear IgA Research and Treatment Project
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract There is no established treatment for progressive IgA nephropathy refractory to steroids and immunosuppressant drugs (r-IgAN). Interleukin 17 (IL-17) blockade has garnered interest in immune-mediated diseases involving the gut-kidney axis. H
Externí odkaz:
https://doaj.org/article/ed42bbc09b42496f80578904f9f518a7
Autor:
Fernando do Pazo-Oubiña, Bartomeu Alorda-Ladaria, Ana Gomez-Lobon, Bàrbara Boyeras-Vallespir, María Margalida Santandreu-Estelrich, Clara Martorell-Puigserver, María Gomez-Zamora, Pere Ventayol-Bosch, Olga Delgado-Sanchez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract More thermolabile drugs are becoming available, and in most cases, these medications are dispensed to ambulatory patients. However, there is no regulation once medications are dispensed to patients and little is known with regard to what hap
Externí odkaz:
https://doaj.org/article/1749a2a11700472b8a3351a1476abff0
Publikováno v:
Journal of Multidisciplinary Healthcare. 16:1037-1046
Ramón Morillo-Verdugo,1 Rosa Morillo-Lisa,2 Jaime Espolita-Suarez,3 Olga Delgado-Sanchez4 1Pharmacy Hospital Service, Hospital Valme, Ãrea de Gestión Sanitaria Sur de Sevilla, Sociedad Española de Farmacia Hospitalaria, Sevilla, Spain; 2R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2e9010d2ae0a9ed00993840eea29921
https://doi.org/10.2147/jmdh.s406636
https://doi.org/10.2147/jmdh.s406636
Publikováno v:
Journal of Multidisciplinary Healthcare.
Ramón Morillo-Verdugo,1 Rosa Morillo-Lisa,2 Jaime Espolita-Suarez,3 Olga Delgado-Sanchez4 1Pharmacy Hospital Service, Hospital Valme, Área de Gestión Sanitaria Sur de Sevilla, Sociedad Española de Farmacia Hospitalaria, Sevilla, Spain; 2Rural Com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051dfd4067919b30a0f582095b2aa418
https://www.dovepress.com/evaluation-of-patient-experience-with-a-model-of-coordinated-telemat-3-peer-reviewed-fulltext-article-JMDH
https://www.dovepress.com/evaluation-of-patient-experience-with-a-model-of-coordinated-telemat-3-peer-reviewed-fulltext-article-JMDH
Autor:
José Vicente Moreno-Muelas, Francisco Zaragozá, Maria Jesús Sanz Ferrando, Kevin Klein, Robin Thorpe, Olga Delgado Sanchez, Joan Albanell, Francisco J. de Abajo
Publikováno v:
Generics and Biosimilars Initiative Journal. 6:31-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1651b8adf4e4f1ea27db2edebac005d0
https://doi.org/10.5639/gabij.2017.0601.007
https://doi.org/10.5639/gabij.2017.0601.007
Autor:
Carmen Ballester Ruiz, B. Andrade, José Ignacio Ayestarán Rota, Sheila Cabello Pelegrin, Antonio Mas Bonet, Javier Lumbreras, Albert Pérez Montaña, Rosa María Ruíz de Gopegui Valero, Lucio Pallares Ferreres, María Jose Picado Valles, Olga Delgado Sanchez, Aina Obrador Mulet, Miguel Giovanni Uriol Rivera, Joana Maria Ferrer Balaguer, Mireia Ferreruela Serlavos
Publikováno v:
PLoS ONE
PLoS ONE, Vol 13, Iss 11, p e0206558 (2018)
PLoS ONE, Vol 13, Iss 11, p e0206558 (2018)
Background Thrombotic microangiopathy (TMA) is an important complication associated with several diseases that are rare and life-threatening. TMA is common to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP is defin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a98089769e8753c5d69c57f89b8ab50
https://doi.org/10.1371/journal.pone.0206558
https://doi.org/10.1371/journal.pone.0206558
Autor:
Miguel Giovanni Uriol Rivera, Javier Lumbreras Fernandez, Sheila Cabello Pelegrin, Olga Delgado Sanchez, Maria del Carmen Ballester Ruiz, B. Andrade
Publikováno v:
Nephrology Dialysis Transplantation. 32:iii137-iii137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa3412302afcba27f24e098e30cb5355
https://doi.org/10.1093/ndt/gfx140.sp101
https://doi.org/10.1093/ndt/gfx140.sp101
Autor:
Ana Castro-Balado, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, Gema Barbeito-Castiñeiras, Ana Estany-Gestal, Rocío Trastoy-Pena, Miguel González-Barcia, Irene Zarra-Ferro, María Carmen del Río-Garma, Carlos Crespo-Diz, Olga Delgado-Sánchez, Francisco J. Otero-Espinar, Cristina Mondelo-García, Antonio Pose-Reino, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 15, Iss 2, p 667 (2023)
Background: Inhaled ethanol in the early stages of SARS-CoV-2 infection may reduce the viral load, decreasing progression and improving prognosis. The ALCOVID-19 trial was designed to study the efficacy and safety of inhaled ethanol in older adults a
Externí odkaz:
https://doaj.org/article/15d5809667904a0aa2a58674a4b84cad
Autor:
Ana Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, Iria Varela-Rey, Ignacio Novo-Veleiro, Néstor Vázquez-Agra, José Ramón Antúnez-López, Enrique José Bandín-Vilar, Raquel Sendón-García, Manuel Busto-Iglesias, Ana Rodríguez-Bernaldo de Quirós, Laura García-Quintanilla, Miguel González-Barcia, Irene Zarra-Ferro, Francisco J. Otero-Espinar, David Rey-Bretal, José Ramón Lago-Quinteiro, Luis Valdés-Cuadrado, Carlos Rábade-Castedo, María Carmen del Río-Garma, Carlos Crespo-Diz, Olga Delgado-Sánchez, Pablo Aguiar, Gema Barbeito-Castiñeiras, María Luisa Pérez del Molino-Bernal, Rocío Trastoy-Pena, Rossana Passannante, Jordi Llop, Antonio Pose-Reino, Anxo Fernández-Ferreiro
Publikováno v:
Pharmaceutics, Vol 13, Iss 3, p 342 (2021)
Inhaled administration of ethanol in the early stages of COVID-19 would favor its location on the initial replication sites, being able to reduce the progression of the disease and improving its prognosis. Before evaluating the efficacy and safety of
Externí odkaz:
https://doaj.org/article/7d1e49fcc0bb49219894ecba2adc497f
Autor:
A. Gomez-Lobon, María Luisa Martin Pena, Melchor Riera Jaume, Pedro Ventayol Bosch, Olga Delgado Sanchez, Maria Peñaranda Vera
Publikováno v:
Infectio, Vol 21, Iss 3, Pp 168-175
Objetivo: El objetivo principal de este trabajo es determinar la tasa de fracaso virológico (FV) en pacientes naive que inician tratamiento antirretroviral (TAR) a 24 y 48 semanas en vida real en un hospital de tercer nivel.Material y método: Estud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a2d1542c1c58ac82fba262afbfb2f0
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922017000300168&lng=en&tlng=en
http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922017000300168&lng=en&tlng=en